The use of well-defined nanovesicles composed of amphiphilic block copolymers (polymersomes) for delivery of adjuvants and antigens is a promising strategy for vaccine development. However, the potency of nanoparticle vaccines depends on efficient interaction with and activation of cells involved in antigen presentation, which can be achieved by targeting cellular receptors. Here, we showed that the Fc fragment display on the polymersome surface resulted in markedly improved interactions with granulocytes, monocytes, and NK cells, while for "naked"polymersomes, virtually no binding to leukocytes was observed. Moreover, CpG-decorated polymersomes were found to also interact with T and/or B cells. Interestingly, whole blood stimulations with ...
Recent advances in the development of protein-based vaccines have expanded the opportunities for pre...
With the focus in the field of cancer nanomedicine shifting from direct tumor targeting to modulatio...
Nanoparticulate carriers are particularly promising and versatile in stimulating immune response. In...
The use of well-defined nanovesicles composed of amphiphilic block copolymers (polymersomes) for del...
Contains fulltext : 239778.pdf (Publisher’s version ) (Open Access
Using poly(propylene sulfide) (PPS) and poly(ethylene glycol) (PEG) as components of a nanocarrier p...
While current subunit vaccines successfully induce humoral immune responses, a need exists for vacci...
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to acti...
The induction of antigen-specific adaptive immunity exclusively occurs in lymphoid organs. As a cons...
The delivery of disease-relevant antigens by nanoparticles is a promising strategy for selectively i...
Cataloged from PDF version of article.Immunostimulatory properties of mushroom derived polysaccharid...
The artificial dsRNA polyriboinosinic acid-polyribocytidylic acid, poly(I:C), is a potent adjuvant c...
It has recently become clear that nanoparticle size is a major determinant for how antigen presentin...
Biomaterials that provide precision control over immune function could enable next generation vaccin...
Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector kill...
Recent advances in the development of protein-based vaccines have expanded the opportunities for pre...
With the focus in the field of cancer nanomedicine shifting from direct tumor targeting to modulatio...
Nanoparticulate carriers are particularly promising and versatile in stimulating immune response. In...
The use of well-defined nanovesicles composed of amphiphilic block copolymers (polymersomes) for del...
Contains fulltext : 239778.pdf (Publisher’s version ) (Open Access
Using poly(propylene sulfide) (PPS) and poly(ethylene glycol) (PEG) as components of a nanocarrier p...
While current subunit vaccines successfully induce humoral immune responses, a need exists for vacci...
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to acti...
The induction of antigen-specific adaptive immunity exclusively occurs in lymphoid organs. As a cons...
The delivery of disease-relevant antigens by nanoparticles is a promising strategy for selectively i...
Cataloged from PDF version of article.Immunostimulatory properties of mushroom derived polysaccharid...
The artificial dsRNA polyriboinosinic acid-polyribocytidylic acid, poly(I:C), is a potent adjuvant c...
It has recently become clear that nanoparticle size is a major determinant for how antigen presentin...
Biomaterials that provide precision control over immune function could enable next generation vaccin...
Binding of monoclonal antibodies (mAbs) onto a cell surface triggers antibody-mediated effector kill...
Recent advances in the development of protein-based vaccines have expanded the opportunities for pre...
With the focus in the field of cancer nanomedicine shifting from direct tumor targeting to modulatio...
Nanoparticulate carriers are particularly promising and versatile in stimulating immune response. In...